Cell
Volume 116, Issue 6, 19 March 2004, Pages 855-867
Journal home page for Cell

Article
Mechanism of Activation of the RAF-ERK Signaling Pathway by Oncogenic Mutations of B-RAF

https://doi.org/10.1016/S0092-8674(04)00215-6Get rights and content
Under an Elsevier user license
open archive

Abstract

Over 30 mutations of the B-RAF gene associated with human cancers have been identified, the majority of which are located within the kinase domain. Here we show that of 22 B-RAF mutants analyzed, 18 have elevated kinase activity and signal to ERK in vivo. Surprisingly, three mutants have reduced kinase activity towards MEK in vitro but, by activating C-RAF in vivo, signal to ERK in cells. The structures of wild type and oncogenic V599EB-RAF kinase domains in complex with the RAF inhibitor BAY43-9006 show that the activation segment is held in an inactive conformation by association with the P loop. The clustering of most mutations to these two regions suggests that disruption of this interaction converts B-RAF into its active conformation. The high activity mutants signal to ERK by directly phosphorylating MEK, whereas the impaired activity mutants stimulate MEK by activating endogenous C-RAF, possibly via an allosteric or transphosphorylation mechanism.

Cited by (0)

6

These authors contributed equally to this work.